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Abstract
MCoTI-I and MCoTI-II from the seeds of Momordica
cochinchinensis are inhibitors of trypsin-like proteases
and the only known members of the large family of
squash inhibitors that are cyclic and contain an additional
loop connecting the amino- and the carboxy-terminus.
To investigate the contribution of macrocycle formation
to biological activity, we synthesized a set of open-chain
variants of MCoTI-II that lack the cyclization loop and
contain various natural and non-natural amino acid sub-
stitutions in the reactive-site loop. Upon replacement of
P1 lysine residue 10 within the open-chain variant of
MCoTI-II by the non-natural isosteric nucleo amino
acid AlaG wb-(guanin-9-yl)-L-alaninex, a conformationally
restricted arginine mimetic, residual inhibitory activity
was detected, albeit reduced by four orders of magni-
tude. While the cyclic inhibitors MCoTI-I and MCoTI-II
were found to be very potent trypsin inhibitors, with pico-
molar inhibition constants, the open-chain variants dis-
played an approximately 10-fold lower affinity. These
data suggest that the formation of a circular backbone in
the MCoTI squash inhibitors results in enhanced affinity
and therefore is a determinant of biological activity.
Keywords: cyclic squash inhibitors; cystine-knot
microproteins; nucleic amino acids; trypsin inhibition.
Introduction
MCoTI-I and MCoTI-II, natural polypeptides isolated from
the seeds of the spinal gourd Momordica cochinchinen-
sis, are plant proteins that have a cyclic backbone and a
knotted arrangement of three conserved disulfide bonds
(Hernandez et al., 2000). The cystine knot (CK) is defined
by three intramolecular disulfide bonds, where CysI-
CysIV and CysII-CysV of the linear peptide sequence
form a ring that is penetrated by the third disulfide bond,
CysIII-CysVI (Figure 1A). This arrangement provides a
well-defined and extremely stable scaffold that exhibits
extraordinary thermal and proteolytic stability (Craik,
2001). Cyclic cystine-knot peptides (cyclotides) have also
been found in Rubicaea and Violaceae, where they have
a wide range of bioactivities, from insecticidal (Jennings
et al., 2001), antimicrobial (Tam et al., 1999), and anti-HIV
functions (Gustafson et al., 2004) to neurotensin binding
(Witherup et al., 1994) and hemolytic activity (Daly et al.,
1999), suggesting potential therapeutic and agricultural
applications (Trabi and Craik, 2002).
Due to structural similarity and common biological
activity, i.e., inhibition of proteases of the trypsin family,
MCoTI-I and MCoTI-II have been grouped into the
squash inhibitor cystine-knot (ICK) family of small pro-
tease inhibitors. Members of this family are open-chain
molecules forming a small triple-stranded b-sheet and a
short 310 helix, held together by three intramolecular
disulfide bonds to give rise to a cystine-knot framework.
Comparison of the backbone conformation of the open-
chain trypsin inhibitors EETI-II (Favel et al., 1989) and
CMTI (Bode et al., 1989) with the cyclic inhibitor MCoTI-
II (Hernandez et al., 2000; Felizmenio-Quimio et al., 2001)
reveals extensive structural similarities among these
molecules.
The contribution of the head-to-tail cyclization of the
backbone to overall microprotein stability and rigidity is
currently not well defined. For the cyclotide kalata B1,
both a loss of biological activity and a disruption of some
structural features that are important to the overall sta-
bility were observed when the macrocycle was opened
and five residues removed (Barry et al., 2003). However,
it appears that the cystine knot is more important than
the circular backbone for the chemical stability of the
cyclotide (Colgrave and Craik, 2004).
Interestingly, in the same natural source of M. cochin-
chinensis, both cyclic and open-chain variants of cystine
knot peptides are found (Hernandez et al., 2000; Figure
1B). It is unclear whether the additional loop sequence
that connects the amino- and the carboxy-terminus con-
tributes to overall stability, framework rigidity, resistance
against proteolytic degradation, or inhibitory activity. To
investigate whether and how backbone cyclization influ-
ences the biological activity of MCoTI-II, i.e., inhibition of
trypsin and trypsin-like proteases, we compared trypsin
inhibition of the cyclotides MCoTI-I and MCoTI-II with the
open-chain variant MCoTI-III and a set of chemically syn-
thesized open-chain variants of MCoTI-II with amino acid
substitutions within the reactive site loop.
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Figure 1 Trypsin inhibitors from M. cochinchinensis.
(A) Schematic representation of the three-dimensional structure of the cyclic trypsin inhibitor McoTI-II (Heitz et al., 2001). Secondary
structure elements are indicated. The disulfide bonds forming the cystine knot architecture and the side chain of the P1 residue lysine
10 are indicated as sticks. The macrocycle-forming loop is shown in black. (B) Amino acid sequences of the naturally occurring
microproteins MCoTI-I, MCoTI-II, and MCoTI-III. Amino acids of the inhibitor loop are indicated in bold letters. -E, amino-terminal
pyro-Glu of MCoTI-III (Hernandez et al., 2000).
Results and discussion
The aim of this study was to elucidate whether backbone
cyclization in the squash inhibitor MCoTI-II, which was
isolated from seeds of M. cochinchinensis by virtue of its
ability to inhibit trypsin (Hernandez et al., 2000; Chiche
et al., 2004), contributes to its biological activity. A set of
open-chain variants of MCoTI-II was synthesized via
9-fluorenylmethoxycarbonyl (Fmoc) synthesis, as de-
scribed recently (Avrutina et al., 2004), and product iden-
tities were confirmed by ESI mass spectroscopy (Table
1). Open-chain MCoTI-II (oMCoTI-II) differs from the nat-
ural cyclic MCoTI-II only in that it lacks part of the cycli-
zation loop (amino acid residues 1–5; Figure 1B). This
loop sequence is also absent in MCoTI-III and not found
in related open-chain trypsin inhibitors from other plants
of the squash family, e.g., CMTI-I (Bode et al., 1989) and
EETI-II (Favel et al., 1989).
Contribution of basic residues within the reactive
site loop to trypsin inhibition
oMCoTI-II is a strongly basic microprotein (calculated pI
8.9), in which three lysine residues are located within the
reactive site loop and two arginines in tandem are directly
adjacent to it. To investigate the contribution of the basic
residues within the inhibitor loop to trypsin binding, an
alanine scanning of K10, K13, and K14 of oMCoTI-II was
performed, together with an individual replacement of
these residues by arginines (Figure 2). As expected from
comparison of the MCoTI-II structure (Heitz et al., 2001)
with structural data of closely related open-chain squash
inhibitors in complex with trypsin (Bode et al., 1989), the
role of lysine 10 of oMCoTI-II as the active-site P1
residue and primary determinant of inhibitor specificity
(Schechter and Berger, 1967) was confirmed, since
replacement by alanine completely abolished trypsin inhi-
bition (Table 1). In contrast, substitution of lysines 13
and 14 by alanine or arginine affected the affinity
towards trypsin only slightly, suggesting that these inhibi-
tor residues contribute little to protease binding.
Replacement of the oMCoTI-II P1 residue by the
non-natural amino acid AlaG
We recently described the synthesis of an oMCoTI-II var-
iant that contains the non-natural amino acid AlaG (Fig-
ure 3) in place of P1 residue K10. AlaG is a peptide
nucleic acid that contains a guanine in its side chain and
is an isosteric, conformationally restricted arginine
mimetic with reduced basicity of the guanidino group
(Lorenz and Diederichsen, 2003) and additional proton
donor and acceptor functionalities. Previous experiments
(Domingo et al., 1995) with synthetic mimetics of the
Bowman-Birk inhibitor containing sets of natural and
non-natural amino acids at the P1 position showed that
only Arg- and Lys-containing peptides were able to bind
to trypsin and to inhibit it. It was concluded that trypsin
inhibition depends not only on the basicity of the P1 resi-
due, but also on steric factors, since a peptide containing
ornithine, an amino acid that differs from lysine only by
a single methylene group, had no measurable trypsin
inhibitory activity (Domingo et al., 1995). In light of these
previous findings, it is interesting to note that oMCoTI-
AlaG retains measurable residual trypsin inhibitory activ-
ity, albeit approximately four orders of magnitude lower
compared to oMCoTI-II and oMCoTI-IIR10, corroborating
the ability of non-natural arginine analogues to act as
basic P1 residues in serine protease inhibitors (Kokko et
al., 2001; McBride and Leatherbarrow, 2001). To under-
stand the influence of steric effects of the AlaG side chain
on trypsin binding and inhibition, structural information is
required. It may therefore be interesting to see whether
it will be possible to obtain a crystal structure of the com-
plex of trypsin with oMCoTI-II or oMCoTI-AlaG.
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Table 1 List of the open-chain and cyclic cystine-knot microproteins studied.
; Peptide Sequence of ESI-MS (m/z) Ki
inhibitor loop
Calculated Measured
(nM)
1 oMCoTI-II -PKILKK- 3066.7 767.78 (Mq4H)4q 0.3
1023.38 (Mq3H)3q
1030.4 (Mq2HqNa)3q
2 oMCoTI-IIA10 -PAILKK- 3010.6 1004.1 (Mq3H)3q NI
1506.0 (Mq2H)2q
3 oMCoTI-IIA13 -PKILAK- 3010.6 753.4 (Mq4H)4q 0.2
1004.1 (Mq3H)3q
1506.0 (Mq2H)2q
4 oMCoTI-IIA14 PKILKA- 3010.6 753.6 (Mq4H)4q 0.4
1004.1 (Mq3H)3q
1505.8 (Mq2H)2q
5 oMCoTI-IIR10 -PRILKK- 3094.7 620.1 (Mq5H)5q 0.8
774.8 (Mq4H)4q
1039.8 (Mq2HqNa)3q
6 oMCoTI-IIR13 -PKILRK- 3094.7 620.1 (Mq5H)5q 0.5
774.8 (Mq4H)4q
780.2 (Mq3HqNa)4q
1032.4 (Mq3H)3q
1039.8 (Mq2HqNa)3q
7 oMCoTI-IIR14 -PKILKR- 3094.7 774.9 (Mq4H)4q 0.4
1032.5 (Mq3H)3q
8 oMCoTI-IIAlaG10 -PAlaGILKK- 3158.7 790.7 (Mq4H)4q 1000
1054.0 (Mq3H)3q
1580.7 (Mq2H)2q
9 MCoTI-I -PKILQR- 3480.96 870.62280 (Mq4H)4q 0.02
696.69980 (Mq5H)5q
10 MCoTI-II -PKILKK- 3452.99 863.63055 (Mq4H)4q 0.03
691.10583 (Mq5H)5q
11 MCoTI-III -PRILKK- 3379.6 845.37633 (Mq4H)4q 0.5
676.50259 (Mq5H)5q
1–8 are synthetic open-chain peptides and 9–11 are natural microproteins from Momordica
cochinchinensis. The amino acid sequences of the respective inhibitor loops are indicated,
as well as ESI MS data and inhibition constants against bovine trypsin. Bold letters indicate
amino acid substitutions. AlaG, peptide nucleic acid with guanidino function in the side chain.
Numbering of amino acids is according to Hernandez et al. (2000). NI, no inhibition detected
at a protein concentration of 10 mM.
Trypsin inhibition of cyclic inhibitors compared to
open-chain variants
The inhibition of trypsin by the open-chain variants of
MCoTI-II was compared with that caused by MCoTI-II
isolated from squash seeds and by the chemically syn-
thesized cyclic MCoTI-I and open-chain MCoTI-III (Figure
4). With an equilibrium dissociation constant Ki of 0.3 nM
(Table 1) the affinity of oMCoTI-II towards trypsin is lower
than that of other open-chain CKIs from squash such as
EETI-II (Favel et al., 1989; Kis0.08 nM). However, cyclic
MCoTI-I and MCoTI-II are more potent inhibitors, with Ki
values of 0.02 and 0.03 nM, respectively, while open-
chain MCoTI-III (0.5 nM) is comparable to open-chain
oMCoTI-II. These data show that the cyclic feature of
MCoTI-I and MCoTI-II contributes to the affinity towards
trypsin.
What is the reason for the differences in trypsin inhi-
bition between the macrocyclic trypsin inhibitors and the
variants lacking a C-to-N cyclization? One possibility
would be that the cyclization loop (SGSDGG) provides
additional binding energy via direct interaction with tryp-
sin that contributes to enhanced binding and inhibition.
Unfortunately, the structure of a complex of a cyclic
squash inhibitor with trypsin has not yet been described,
and structural data of the open-chain variants are also
not available. To determine whether any of the six cycli-
zation-loop residues could contribute to trypsin binding,
we used the structures of the complex of the squash
inhibitor EETI-II with porcine trypsin (Kra¨tzner et al., 2005)
and of free MCoTI-II (Heitz et al., 2001) and of bovine
trypsin as templates to model the interaction of this
microprotein with trypsin (Figure 5). According to the
model, none of the trypsin residues comes into proximity
to the connecting loop closer than 5.0 A˚. Only valine 7,
which is directly adjacent to the connecting loop and is
present in our open-chain variants of MCoTI-II, is close
to trypsin residues, namely tryptophan 215 and tyrosine
175 (2.1 and 2.6 A˚, respectively) These two residues
are good candidates to provide binding energy by hydro-
phobic interactions with the side chain of valine 7,
which may be in a position more favorable for trypsin
interaction when placed adjacent to the conformationally
constrained cyclization loop of MCoTI-II. Notably, alanine
and not valine is present in MCoTI-III at this position (Fig-
ure 1) and replacement of valine 7 by alanine both in
cyclic and open-chain MCoTI-II could clarify whether this
residue significantly contributes to trypsin binding. More-
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Figure 2 Amino acid sequence and disulfide bond connectivity of the cyclotide MCoTI-II (upper panel) and the open-chain variants
described in this study (lower panel).
Figure 3 Nucleo amino acid AlaG (2) as an isoster for Arg (1).
The isosteric relationship between Arg and AlaG is marked with
highlighted bonds.
over, other indirect contributions of the connecting loop
to enhanced trypsin inhibition appear possible. For
example, N-to-C macrocycle formation is likely to intro-
duce additional conformational rigidity into the already
constrained molecule, which subsequently could contrib-
ute to a better fit of the inhibitor loop into the active site
of the enzyme.
Conclusion
In the current study we determined the affinity of the nat-
ural cyclic CKIs MCoTI-I and MCoTI-II towards trypsin
compared with the natural open-chain variant MCoTI-III
and a series of MCoTI-II derivatives lacking the macro-
cycle-forming loop. Alanine scanning mutagenesis sug-
gests that MCoTI-II binds, similar to other inhibitors of
the squash family, the target enzyme in a substrate-like
manner, with lysine 10 in the inhibitor loop acting as P1
residue and determinant of selectivity, while the side
chains of the other two basic residues in the inhibitor
loop contribute to trypsin binding only to a small extent.
Compared to the cyclic inhibitors MCoTI-I and MCoTI-
II that are very potent trypsin inhibitors, the affinity of the
open-chain variants is approximately 10-fold lower. More
structural information on the cyclic and open-chain forms
of MCoTI-II in solution and in complex with trypsin is
required to clarify why the cyclic squash inhibitor MCoTI-
II is a better trypsin inhibitor than its open-chain
counterpart.
Materials and methods
Materials
All chemicals used were of the highest grade available. Solvents
were of analytical grade and used as supplied. Fmoc-protected
amino acids were used with the following side-chain protecting
groups: tert-butyl (Asp, Tyr), tert-butoxycarbonyl (Lys), trityl (Cys,
Asn), 2,2,4,6,7-pentamethyldihydro-benzofuran-5-sulfonyl (Arg).
Pseudo-proline dipeptide Fmoc-Asp(OtBu)-Ser(cMe,Me)pro-OH
was purchased from Calbiochem-Novabiochem GmbH (Schwal-
bach, Germany). Electrospray ionization (ESI) mass spectra were
measured with a Finnegan (San Jose, USA) LCQ spectrometer.
High-resolution ESI mass spectra were recorded with a Bruker
APEX-Q III 7T. High-performance liquid chromatography (HPLC)
was performed with a Pharmacia (Freiburg, Germany) A¨cta basic
system using YMC (Dinslaken, Germany) J’sphere ODS H-80,
RP C-18 (250=20 mm, 4 mm, 8 nm) and Phenomenex (Aschaf-
fenburg, Germany) Synergi 4u Hydro-RP 80A (250=10 mm,
4 mm, 8 nm) columns for preparative separations and YMC
J’sphere ODS H-80, RP C-18 (250=4.6 mm, 4 mm, 8 nm) and
Phenomenex Synergi 4u Hydro-RP 80A (250=4.6 mm, 4 mm,
8 nm) for analytical samples.
Reference microproteins: MCoTI-I, MCoTI-II and
MCoTI-III
Cyclotide MCoTI-II was isolated from the seeds of M. cochin-
chinensis (Hernandez et al., 2000). Cyclic MCoTI-I and open-
chain MCoTI-III were synthesized on a solid support. Details on
the preparation of synthetic peptides will be published else-
where.
Synthesis and oxidation of oMCoTI-II peptides
Peptide synthesis was conducted using Fmoc solid-phase pep-
tide synthesis (SPPS) on PEG-type amide NovaSyn TGR resin
(Calbiochem-NovaBiochem) with a loading capacity of 0.23
mmol/g and involved several steps. After manual attachment
of the C-terminal glycine as previously described (Avrutina et al.,
2004), the linear precursor was assembled up to C10 using the
automated mode on an ABI 433 peptide synthesizer. The con-
ditions for the deprotection, activation, and coupling of all amino
acids except cysteine were the same as described by Avrutina
et al. (2004). For the self-automated incorporation of cysteine,
an additional program was created to provide conditions for rac-
emization-free coupling: N,N-diisopropyl carbodiimide (DIC)/
1-hydroxy-1H-benzotriazole (HOBt) activation with 10-min pre-
activation and coupling time of 1 h 20 min. DIPEA delivery was
removed from the activation cycle by manual programming.
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Figure 4 Inhibition of trypsin by the naturally occurring cyclic
MCoTI-I (triangles) and MCoTI-II (squares), the open-chain
MCoTI-III (diamonds), and the synthetic open-chain variant
oMCoTI-II (circles).
For each inhibitor, two inhibition curves are shown that were
generated by fitting data derived from separate experiments
(open and filled symbols) to Eq. (1), as described in the materials
and methods section.
Figure 5 Model of the complex of MCoTI-II with trypsin.
The structure of MCoTI-II (PDB entry 1HA9) was superimposed onto the structure of the squash inhibitor EETI-II in complex with
porcine trypsin (see materials and methods). The side chains of the trypsin residues Y172 and W215 that are located in proximity to
V7 of MCoTI-II are displayed as sticks and spheres.
HOBt was added as a solid directly onto the amino acid
cartridge according to a standard coupling protocol (Albericio
et al., 2000), and DIC was used as a 5% solution in di-
chloromethane. To achieve practical DIC addition, methanol
from the bottle at position 5 was replaced with an activator solu-
tion, and the time was regulated to deliver 2 ml of 5% DIC into
the cartridge.
After automated peptide synthesis, the resin was dried and a
small portion was subjected to a test cleavage to assess the
quality of the peptide. Then portions of 100 mg each were
placed into polypropylene syringes, and the synthesis was con-
tinued manually to obtain different resin-bound polypeptides
with altered inhibitor-loop sequences.
The peptide resins were dried for 24 h and the peptides were
then cleaved off by treatment with trifluoroacetic acid, purified
by HPLC, air-oxidized and re-purified by HPLC to give folded
microproteins (Avrutina et al., 2004; Table 1).
Enzymatic methods
The concentrations of the inhibitory active microproteins were
determined by titration with trypsin. Therefore, bovine pancreatic
trypsin (N-p-tosyl-L-phenylalanine chloromethyl ketone-treated;
Sigma, Munich, Germany) was standardized by active-site titra-
tion using p-nitrophenyl-p9-guanidinobenzoate (Chase and
Shaw, 1970). Trypsin (25 nM) was then incubated with serial dilu-
tions of an inhibitor in buffer (50 mM Tris/HCl, 150 mM NaCl,
0.01% Triton X-100, 0.01% sodium azide, pH 7.6). After 30 min,
carbobenzoxy-L-arginine-7-amino-4-methylcoumarin (75 mM;
Sigma) was added, and the residual activity was quantified by
following the hydrolysis of the substrate over 10 min. Measure-
ments were performed in 96-well plates (Corning, Corning, USA)
at room temperature using a HTS 7000 Bio Assay Reader (Perkin
Elmer, Rodgau-Ju¨gesheim, Germany) with excitation and emis-
sion wavelengths of 360 and 465 nm, respectively. The concen-
tration of the active inhibitor was calculated from inhibition
curves obtained in two separate experiments assuming a 1:1
interaction between inhibitor and trypsin.
Equilibrium dissociation constants (Ki) for the complexes
of the inhibitors with trypsin were determined essentially as
described above, but using an enzyme concentration in the
range of or lower than Ki (Bieth, 1980). Thus, trypsin (0.005 or
0.6 nM) was incubated with serial dilutions of an inhibitor in buf-
fer for 30–90 min; the time required to reach equilibrium was
verified in separate experiments. The residual trypsin activity
was then measured following the breakdown of 5 mM N-p-tosyl-
glycine-proline-arginine-7-amido-4-methylcoumarin (Sigma) or
75 mM carbobenzoxy-L-arginine-7-amino-4-methylcoumarin.
The data were fitted to Eq. (1) (Morrison, 1969) using a Leven-
berg-Marquardt algorithm with proFit (Quantum Soft, Uetikon
am See, Switzerland):
B E2EqIqKy EqIqK y4E IyŽ . Ž .0 0 0 0 0 0C Fvsv 1y (1)i 0 2ED G0
where v0 and vi are the enzyme activity measured in the absence
and presence of the inhibitor, and E0 and I0 the total enzyme and
inhibitor concentrations, respectively. Under the experimental
conditions used, addition of substrate does not cause significant
dissociation of the enzyme-inhibitor complex, so that KsKi. Ki
values determined in separate experiments differed by less than
two-fold for all inhibitors, and averages of at least two experi-
ments are reported.
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Modeling of the trypsin MCoTI-II complex
Starting structures were the NMR structure of McoTI-II (PDB
entry 1HA9; Heitz et al., 2001) and the crystal structure of a
complex of EETI-II with porcine trypsin (PDB entry 1H9H; Kra¨tz-
ner et al., 2005). MCoTI-II was superimposed onto the EETI-II
structure by pairwise superposition of structurally equivalent
heavy atom pairs of all six cysteine residues using PYMOL
(Delano, 2002).
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